Study of The Structural–Mechanical Parameters and Technological Properties of Coenzyme Q10 Substance

Abstract

To The comprehensive evaluation of the physicochemical, structural–mechanical, and technological properties of active pharmaceutical ingredients (APIs) is a crucial stage in the development of solid dosage forms. Particle size, particle morphology, flowability, compressibility, and frictional properties directly affect the stability of the manufacturing process and the quality of the final pharmaceutical product. Therefore, the determination of these characteristics provides a scientific basis for selecting the type and quantity of pharmaceutical excipients, optimizing the granulation process, and improving technological parameters. Consequently, these evaluations ensure dose uniformity, adequate mechanical strength, appropriate disintegration and dissolution characteristics, and ultimately contribute to the development of high-quality and stable pharmaceutical formulations [1].

Keywords:

Coenzyme Q10, particle size, particle morphology

References

Demchuk M.B., Gureeva S.N., Groshoviy T.A. Tabletlangan dori preparatlarini yaratish, ishlab chiqarish va tadqiq qilishning zamonaviy holati: multipartikulyar pellet tizimlarini ishlab chiqish // Farmatsevtik jurnal.-2015.-№ 19.-B. 29–42.

Ho M.J., Li E.C.K., Wright J.M. Effect of coenzyme Q10 on blood pressure//Cochrane Database Syst. Rev.-2016.-CD007435.-URL: https://www.dev.epocrates.com/epocrates/sites/epocrates/files/res/dacc/2016/BPLoweringEfficacyofQ10Cochrane1604.

Samimi F., et al. Coenzyme Q10: A Key Antioxidant in the Management of Cardiovascular Complications Induced by Diabetes // Int. J. Endocrinol. -2024. -Art. 2247748. -DOI: 10.1155/2024

Aleagen G., et al. Coenzyme Q10 and vascular aging in hypertension: clinical and experimental insights // Journal of Hypertension Research.-2024.-№12.-P. 145–158.

Garrido-Maraver J., et al. Clinical applications of Coenzyme Q10 // Molecular Syndromology.-2025.-Vol. 16(1).-P. 45–60.

Vaxidova N.M., Maksudova F.X. Valsartan, askorbin kislotasi va koenzim 10 substansiyalarning texnologik ko’rsatkichlarini o’rganish // Farmatsevtika sohasining bugungi holati: muammolar va istiqbollar” mavzusidagi VI xalqaro ilmiy-amaliy anjuman. Toshkent.-2025.-B.106.

Vaxidova N.M., Maksudova F.X. Valsartan va sakubitril substansiyalarining struktura-mexanik va texnologik xossalarini o‘rganish borasidagi tadqiqotlar // Farmasevtika jurnal. Tom.-34. №6. Toshkent.-2025.

ISSN 2010-7145.-B.36-40.

O’zbekiston Respublikasi davlat farmakopeyasi 1-nashr, 1-jild, 1-qism. Toshkent.-2021.

European Pharmacopoeia 11th Edition, Supplement 11.4. Strasbourg: EDQM, 2023. Koenzim Q10 substansiyasi.

Maksudova F.X.., Vaxidova N.M.., Baxtiyorova Z.B. Valsartan va koenzim Q10 asosidagi «CoValis» kapsulalarining sifat ko‘rsatkichlarini aniqlash // “Ilm-fan va innovatsiya” Respublika Ilmiy-amaliy konfrensiyasi. B.83-84.